Clinical trial
Tacrolimus and Mycophenolate Mofetil (MMF) in GVHD Prophylactic Regimen Compared…
NCT00360685 · H. Lee Moffitt Cancer Center and Research Institute, Other · Completed
Key facts
| NCT number | NCT00360685 |
|---|---|
| Title | Tacrolimus and Mycophenolate Mofetil (MMF) in GVHD Prophylactic Regimen Compared to Tacrolimus and Methotrexate (MTX |
| Official title | Safety of Tacrolimus And Methotrexate (MTX) Versus Tacrolimus And Mycophenolate Mofetil (MMF) As Graft Versus Host Disease Prophylaxis In Allogeneic Hematopoietic Cell Transplants (HCT) |
| Lead sponsor | H. Lee Moffitt Cancer Center and Research Institute, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Mucositis, Graft-versus-host Disease |
| Intervention type | Drug |
| Interventions | Tac+MTX, TAC + MMF |
| Enrollment | 89 |
| Start date | Sep 1, 2005 |
| Primary completion | Jan 1, 2011 |
| Completion | Jan 1, 2011 |
| First posted | Aug 7, 2006 |
| Last update posted | May 3, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: